Selective Nuclear Export Inhibitor KPT-330 Enhances the Antitumor Activity of Gemcitabine in Human Pancreatic Cancer. [electronic resource]
Producer: 20160510Description: 1570-81 p. digitalISSN:- 1538-8514
- Active Transport, Cell Nucleus -- drug effects
- Animals
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Apoptosis -- drug effects
- Blotting, Western
- Cell Adhesion -- drug effects
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Cell Survival -- drug effects
- Cyclin-Dependent Kinase Inhibitor p27 -- metabolism
- Deoxycytidine -- administration & dosage
- Dose-Response Relationship, Drug
- Drug Synergism
- Female
- Humans
- Hydrazines -- administration & dosage
- Mice, Nude
- Microscopy, Confocal
- Pancreatic Neoplasms -- drug therapy
- Triazoles -- administration & dosage
- Tumor Burden -- drug effects
- Xenograft Model Antitumor Assays
- Gemcitabine
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.